abstract |
The invention relates to (S)-[2-chloro-4-fluoro-5- (7-morpholin-4-ylquinazolin-4-yl) phenyl]-(6-methoxy-ta -3-yl) methanol or a pharmaceutically acceptable salt of the pharmaceutical formulations, the method of manufacturing the same, and its medical use. |